Arkolith/Insider Trading/TARS/Form 4

Link William J PHD

DirectorTarsus Pharmaceuticals, Inc. (TARS) · full profile →Form 4 · filed Mar 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$860K
Net Open-Market Flow
-$860K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)8K$69.03$578K117K
Mar 16, 2026Sell(S)493$69.75$34K116K
Mar 16, 2026Sell(S)4K$68.09$247K125K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001228684-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML